BioNTech aims for 2 billion Covid-19 vaccine doses in 2021
"We now believe that we can potentially deliver approximately 2 billion doses in total by the end of 2021, which incorporates the updated 6-dose label," BioNTech said in a presentation
"Scientifically, it is highly likely that the immune response by this vaccine also can deal with the new virus variant," said Ugur Sahin, chief executive of the company. Photo: Collected
German Covid-19 vaccine maker BioNTech, partner of U.S. pharmaceutical group Pfizer , said on Monday it aims to produce two billion doses of its vaccine this year.
"We now believe that we can potentially deliver approximately 2 billion doses in total by the end of 2021, which incorporates the updated 6-dose label," BioNTech said in a presentation.
Keep updated, follow The Business Standard's Google news channel
